drugset / Trial / NCT06987916
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label phase1 study to assess the safety and efficacy of U01(ssCART-19) cell therapy in the treatment of patients with refractory or recurrent B-cell lymphoma .
Timeline
- Start
- 2025-04-22
- Primary completion
- 2028-04-22
- Completion
- 2030-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ssCART-19 | Cell therapy | — | — |